We are live on ! Find out more
PAMU

Pictet Asset Management (UK) Portfolio holdings

AUM $91.8B
1-Year Est. Return 47.77%
This Fund
S&P 500
This Quarter Est. Return
+7.64%
1 Year Est. Return
+47.77%
3 Year Est. Return
+102.96%
5 Year Est. Return
+189.45%
10 Year Est. Return
AUM
$91.8B
AUM Growth
+$8.58B
Cap. Flow
+$2.33B
Cap. Flow %
2.53%
Top 10 Hldgs %
12.39%
Holding
1,892
New
100
Increased
613
Reduced
867
Closed
139

Sector Composition

Rank Sector Weight
1 Technology 28.89%
2 Healthcare 15.52%
3 Industrials 13.05%
4 Consumer Discretionary 9.92%
5 Utilities 8.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TTC icon
101
Toro Company
TTC
$8.93B
$270M 0.29%
2,455,743
-26,338
-1% -$2.9M
JPM icon
102
JPMorgan Chase
JPM
$939B
$267M 0.29%
1,714,923
-81,936
-5% -$12.9M
REGN icon
103
Regeneron Pharmaceuticals
REGN
$68.8B
$263M 0.29%
471,560
+38,800
+9% +$19.7M
EVRG icon
104
Evergy
EVRG
$20.1B
$263M 0.29%
4,346,240
-305,056
-7% -$19.1M
MAS icon
105
Masco
MAS
$16B
$263M 0.29%
4,456,749
-335,549
-7% -$20.7M
VRTX icon
106
Vertex Pharmaceuticals
VRTX
$121B
$261M 0.28%
1,293,145
+50,686
+4% +$10.6M
ALTR
107
DELISTED
Altair Engineering Inc
ALTR
$258M 0.28%
3,746,094
+46,199
+1% +$3.03M
POOL icon
108
Pool Corp
POOL
$6.7B
$253M 0.28%
550,517
-52,304
-9% -$22M
AXP icon
109
American Express
AXP
$223B
$246M 0.27%
1,489,683
+227,406
+18% +$35.6M
MTCH icon
110
Match Group
MTCH
$8.84B
$244M 0.27%
1,514,894
+393,398
+35% +$57.6M
SBUX icon
111
Starbucks
SBUX
$118B
$243M 0.27%
2,176,056
+276,380
+15% +$31.2M
MRVL icon
112
Marvell Technology
MRVL
$174B
$242M 0.26%
4,149,303
+1,457,234
+54% +$71.2M
DIS icon
113
Walt Disney
DIS
$165B
$235M 0.26%
1,339,766
-3,695
-0.3% -$665K
EXC icon
114
Exelon
EXC
$48.6B
$235M 0.26%
7,436,054
-514,481
-6% -$16.6M
PEG icon
115
Public Service Enterprise Group
PEG
$39.8B
$232M 0.25%
3,878,634
-263,923
-6% -$16.3M
SGEN
116
DELISTED
Seagen Inc. Common Stock
SGEN
$231M 0.25%
1,462,857
+216,394
+17% +$32.2M
INTU icon
117
Intuit
INTU
$81.1B
$229M 0.25%
467,497
-202,287
-30% -$87.7M
WDAY icon
118
Workday
WDAY
$33.4B
$226M 0.25%
948,642
+350,574
+59% +$84.3M
ALB icon
119
Albemarle
ALB
$13.5B
$225M 0.25%
1,336,359
-92,959
-7% -$15M
ZTS icon
120
Zoetis
ZTS
$31.6B
$222M 0.24%
1,192,908
+166,305
+16% +$28.9M
EIX icon
121
Edison International
EIX
$30.7B
$222M 0.24%
3,835,356
-262,713
-6% -$15.3M
IP icon
122
International Paper
IP
$22.3B
$221M 0.24%
3,804,704
+2,286,158
+151% +$131M
CRWD icon
123
CrowdStrike
CRWD
$187B
$221M 0.24%
3,514,044
+970,732
+38% +$52.2M
STE icon
124
Steris
STE
$20.9B
$214M 0.23%
1,037,940
-180,321
-15% -$36.3M
HZNP
125
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$213M 0.23%
2,279,478
+254,092
+13% +$23.4M

Similar funds

Pictet Asset Management (UK)'s Q2 2021 Portfolio in Review

As of Q2 2021, Pictet Asset Management (UK) held 1,892 positions worth $91.8B, up 10% from $83.2B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Pictet Asset Management (UK)'s Q2 2021 filing shows 100 new, 613 increased, 867 reduced and 139 closed positions. Its largest new stake was Oatly Group: 140,026 shares worth $68.5M. The largest sale was Alibaba, an estimated $550M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 29% a quarter earlier, followed by Healthcare and Industrials.

  • Pictet Asset Management (UK)'s largest Q2 2021 buy was Oatly Group: 140,026 shares worth $68.5M.
  • Pictet Asset Management (UK) added most to Equinix in Q2 2021, an estimated $221M increase.
  • Pictet Asset Management (UK)'s biggest Q2 2021 reduction was Alibaba, cutting an estimated $550M.
  • Pictet Asset Management (UK) fully exited ChemoCentryx, Inc. in Q2 2021, selling an estimated $62.6M.
  • Pictet Asset Management (UK)'s ten largest holdings make up 12% of its $91.8B portfolio in Q2 2021.
  • Pictet Asset Management (UK) opened 100 new positions and closed 139 in Q2 2021.
  • Pictet Asset Management (UK)'s portfolio value rose 10% quarter-over-quarter to $91.8B.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.